HANQUYOU Marks 3rd Anniversary with Brilliant Achievements
(Adnkronos) – SHANGHAI, July 28, 2023 /PRNewswire/ — HANQUYOU (trastuzumab, trade name in Europe: Zercepac®; trade names in Australia: Tuzucip® and Trastucip®), the first China-developed trastuzumab biosimilar independently developed by Shanghai Henlius Biotech, Inc.
